# Feasibility Study of the FARAFLEX Mapping and PFA System

> **NCT06510556** · NA · RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 250 (estimated)

## Conditions studied

- Atrial Fibrillation
- Persistent Atrial Fibrillation
- Paroxysmal AF

## Interventions

- **DEVICE:** FARAFLEX Ablation Treatment
- **DEVICE:** Commercial Sub-study Treatment

## Key facts

- **NCT ID:** NCT06510556
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-17
- **Primary completion:** 2027-02-15
- **Final completion:** 2027-09-15
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06510556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06510556, "Feasibility Study of the FARAFLEX Mapping and PFA System". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06510556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*